Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$4.62 USD
+0.14 (3.13%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.61 -0.01 (-0.22%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Vanda Pharmaceuticals Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2.51 | 6.28 | 33.15 | 23.34 | 115.55 |
Depreciation/Amortization & Depletion | -5.79 | -0.23 | 4.49 | 3.04 | -0.21 |
Net Change from Assets/Liabilities | -0.75 | 6.07 | 2.74 | 4.32 | 3.13 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 16.83 | 19.87 | 23.84 | 21.08 | -72.52 |
Net Cash From Operating Activities | 12.80 | 31.98 | 64.21 | 51.78 | 45.95 |
Property & Equipment | -101.05 | -0.68 | -0.55 | -1.80 | -1.02 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 88.99 | 50.60 | -76.14 | -39.70 | -67.29 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -12.06 | 49.93 | -76.70 | -41.50 | -68.31 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.73 | 3.55 | 5.63 | 6.26 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.00 | 0.73 | 3.55 | 5.63 | 6.26 |
Effect of Exchange Rate Changes | 0.05 | 0.27 | -0.09 | 0.05 | 0.00 |
Net Change In Cash & Equivalents | 0.79 | 82.91 | -9.02 | 15.96 | -16.10 |
Cash at Beginning of Period | 135.50 | 52.59 | 61.61 | 45.65 | 61.75 |
Cash at End of Period | 136.29 | 135.50 | 52.59 | 61.61 | 45.65 |
Diluted Net EPS | 0.04 | 0.11 | 0.58 | 0.42 | 2.11 |
Fiscal Year End for Vanda Pharmaceuticals Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 2.51 | 4.91 | 4.77 | 3.25 |
Depreciation/Amortization & Depletion | NA | -5.79 | -5.20 | -2.97 | -1.62 |
Net Change from Assets/Liabilities | NA | -0.75 | -3.57 | 3.21 | 22.04 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 16.83 | 20.39 | 13.57 | 8.13 |
Net Cash From Operating Activities | NA | 12.80 | 16.53 | 18.58 | 31.80 |
Property & Equipment | NA | -101.05 | -0.13 | -0.11 | -0.05 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 88.99 | 31.86 | -3.49 | 187.35 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -12.06 | 31.73 | -3.60 | 187.29 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.05 | -0.10 | 0.02 | 0.05 |
Net Change In Cash & Equivalents | NA | 0.79 | 48.16 | 15.00 | 219.14 |
Cash at Beginning of Period | NA | 135.50 | 135.50 | 135.50 | 135.50 |
Cash at End of Period | NA | 136.29 | 183.66 | 150.50 | 354.64 |
Diluted Net EPS | NA | -0.05 | 0.00 | 0.03 | 0.06 |